Delta Financial Group Inc. Buys New Stake in Church & Dwight Co., Inc. (NYSE:CHD)

Delta Financial Group Inc. acquired a new position in Church & Dwight Co., Inc. (NYSE:CHD) during the fourth quarter, according to the company in its most recent filing with the SEC. The fund acquired 4,696 shares of the company’s stock, valued at approximately $492,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CHD. International Assets Investment Management LLC purchased a new position in Church & Dwight in the 3rd quarter valued at about $44,630,000. IFM Investors Pty Ltd lifted its position in shares of Church & Dwight by 3.2% during the third quarter. IFM Investors Pty Ltd now owns 49,762 shares of the company’s stock worth $5,211,000 after purchasing an additional 1,520 shares during the last quarter. Mount Yale Investment Advisors LLC lifted its position in shares of Church & Dwight by 24.4% during the third quarter. Mount Yale Investment Advisors LLC now owns 8,588 shares of the company’s stock worth $899,000 after purchasing an additional 1,686 shares during the last quarter. Ballentine Partners LLC lifted its position in shares of Church & Dwight by 13.1% during the third quarter. Ballentine Partners LLC now owns 11,062 shares of the company’s stock worth $1,158,000 after purchasing an additional 1,285 shares during the last quarter. Finally, Elwood & Goetz Wealth Advisory Group LLC bought a new position in shares of Church & Dwight during the third quarter worth about $367,000. 86.60% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages have recently commented on CHD. Deutsche Bank Aktiengesellschaft increased their price target on shares of Church & Dwight from $114.00 to $115.00 and gave the stock a “buy” rating in a research report on Monday, November 4th. Stifel Nicolaus increased their price objective on shares of Church & Dwight from $103.00 to $105.00 and gave the stock a “hold” rating in a research note on Monday, February 3rd. Wells Fargo & Company raised their price target on shares of Church & Dwight from $113.00 to $115.00 and gave the company an “overweight” rating in a research note on Monday, November 4th. Barclays raised their price target on shares of Church & Dwight from $90.00 to $93.00 and gave the company an “underweight” rating in a research note on Tuesday, February 4th. Finally, Piper Sandler dropped their price target on shares of Church & Dwight from $128.00 to $126.00 and set an “overweight” rating on the stock in a research note on Monday, February 3rd. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $111.47.

Church & Dwight Trading Up 0.9 %

Shares of NYSE:CHD opened at $105.40 on Friday. The stock has a market capitalization of $25.93 billion, a price-to-earnings ratio of 44.47, a PEG ratio of 3.32 and a beta of 0.59. Church & Dwight Co., Inc. has a 1-year low of $96.35 and a 1-year high of $113.50. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.24 and a current ratio of 1.70. The company has a 50 day moving average price of $105.35 and a 200 day moving average price of $104.72.

Church & Dwight (NYSE:CHD) last issued its earnings results on Friday, January 31st. The company reported $0.77 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.77. Church & Dwight had a net margin of 9.58% and a return on equity of 20.03%. During the same quarter in the previous year, the business earned $0.65 earnings per share. On average, research analysts anticipate that Church & Dwight Co., Inc. will post 3.7 EPS for the current fiscal year.

Church & Dwight Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 3rd. Investors of record on Friday, February 14th will be paid a $0.295 dividend. This is a positive change from Church & Dwight’s previous quarterly dividend of $0.28. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.18 dividend on an annualized basis and a yield of 1.12%. Church & Dwight’s dividend payout ratio (DPR) is currently 49.79%.

Insider Buying and Selling

In related news, EVP Michael Read bought 1,100 shares of the business’s stock in a transaction on Monday, December 16th. The stock was bought at an average price of $106.82 per share, for a total transaction of $117,502.00. Following the transaction, the executive vice president now directly owns 2,505 shares in the company, valued at $267,584.10. This represents a 78.29 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Rick Spann sold 39,520 shares of the stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $112.00, for a total transaction of $4,426,240.00. Following the completion of the sale, the executive vice president now owns 4,973 shares of the company’s stock, valued at approximately $556,976. The trade was a 88.82 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 49,522 shares of company stock valued at $5,487,555. Company insiders own 2.00% of the company’s stock.

Church & Dwight Company Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.